scholarly article | Q13442814 |
P356 | DOI | 10.1034/J.1600-0714.2003.00077.X |
P8608 | Fatcat ID | release_e2ye4j7yxvalrggvmzaeskbg3a |
P698 | PubMed publication ID | 12542829 |
P50 | author | Laurence J. Walsh | Q40157190 |
P2093 | author name string | Camile S Farah | |
Ambereen Khan | |||
Neil W Savage | |||
Philip B Sugerman | |||
Doug J Harbrow | |||
P433 | issue | 2 | |
P304 | page(s) | 77-83 | |
P577 | publication date | 2003-02-01 | |
P1433 | published in | Journal of Oral Pathology & Medicine | Q15724686 |
P1476 | title | Th1 cytokines in oral lichen planus | |
P478 | volume | 32 |
Q81230274 | Alteration of the expression of CD44 [corrected] isoforms in oral epithelia and saliva from patients with oral lichen planus |
Q79789927 | Assessment of local angiogenesis and vascular endothelial growth factor in the patients with atrophic-erosive and reticular oral lichen planus |
Q37192618 | Association of genetic polymorphisms in interferon-γ, interleukin-6 and transforming growth factor-β1 gene with oral lichen planus susceptibility |
Q42874968 | Caspase cascade pathways in apoptosis of oral lichen planus. |
Q84516597 | Changes in saliva interleukin-6 levels in patients with oral squamous cell carcinoma |
Q36161959 | Current controversies in oral lichen planus: report of an international consensus meeting. Part 1. Viral infections and etiopathogenesis |
Q36134951 | Cutaneous manifestations of systemic lupus erythematosus. |
Q42485292 | Decreased antioxidant enzyme expression and increased oxidative damage in erosive lichen planus of the vulva |
Q36966214 | Detection of T cells secreting type 1 and type 2 cytokines in the peripheral blood of patients with oral lichen planus |
Q36151744 | Distinct interferon-gamma and interleukin-9 expression in cutaneous and oral lichen planus |
Q38386935 | Downregulation of toll-like receptor-mediated signalling pathways in oral lichen planus. |
Q57293585 | Efficacy of photobiomodulation on oral lichen planus: a protocol study for a double-blind, randomised controlled clinical trial |
Q54374574 | Enhanced expression of Toll-like receptor 2 in lesional tissues and peripheral blood monocytes of patients with oral lichen planus. |
Q42428071 | Evaluation of Serum TNF-α and TGF-β in Patients with Oral Lichen Planus |
Q48201555 | Experimental study on 1,25(OH)2 D3 amelioration of oral lichen planus through regulating NF-κB signaling pathway. |
Q41922757 | Hydroxychloroquine decreases the upregulated frequencies of Tregs in patients with oral lichen planus |
Q47999940 | IFN-gamma and IL-4 in saliva of patients with oral lichen planus: a study in an ethnic Chinese population. |
Q48351628 | IL17A polymorphism and elevated IL17A serum levels are associated with oral lichen planus |
Q45330646 | Immunohistochemical expression of p16(INK4A) protein in oral lichen planus |
Q42466441 | Immunohistochemical expression of perforin in lichen planus lesions |
Q37526968 | Immunosuppression Induced by Chronic Inflammation and the Progression to Oral Squamous Cell Carcinoma |
Q43931074 | Implications of Th1 and Th17 cells in pathogenesis of oral lichen planus |
Q83696187 | Increased B7-H1 expression on peripheral blood T cells in oral lichen planus correlated with disease severity |
Q89167196 | Increased expression of p16 in both oral and genital lichen planus |
Q38170492 | Inflammation-related cytokines in oral lichen planus: an overview |
Q37667332 | Interferon-γ and interleukin-4 detected in serum and saliva from patients with oral lichen planus |
Q49181571 | LPS-induced Vitamin D Receptor Decrease in Oral Keratinocytes Is Associated With Oral Lichen Planus |
Q34591322 | Levels of salivary IFN-gamma, TNF-alfa, and TNF receptor-2 as prognostic markers in (erosive) oral lichen planus |
Q57015726 | Lichen Planus |
Q42172720 | Mast cells distribution and variations in epithelium thickness and basement membrane in oral lichen planus lesion and oral lichenoid reaction |
Q41048077 | Memory T Cells (CD45RO) Role and Evaluation in Pathogenesis of Lichen Planus and Lichenoid Mucositis |
Q45864277 | Mesenchymal stem cell transplantation: A potential therapy for oral lichen planus |
Q57618782 | Modulation of Serum Anti-thyroglobulin and Anti-thyroid Microsomal Autoantibody Levels by Levamisole in Patients With Oral Lichen Planus |
Q57618783 | Modulation of Serum Antinuclear Antibody Levels by Levamisole Treatment in Patients With Oral Lichen Planus |
Q59335312 | Modulation of salivary cytokines in response to alcohol, tobacco and caffeine consumption: a pilot study |
Q62898463 | Oral Lichen Planus |
Q88817474 | Oral Lichen Planus: an Overview of Potential Risk Factors, Biomarkers and Treatments |
Q35325005 | Oral lichen planus (OLP), oral lichenoid lesions (OLL), oral dysplasia, and oral cancer: retrospective analysis of clinicopathological data from 2002-2011. |
Q59800047 | Oral lichen-planus-associated fibroblasts acquire myofibroblast characteristics and secrete pro-inflammatory cytokines in response to Porphyromonas gingivalis lipopolysaccharide stimulation |
Q33999055 | Overexpression and selectively regulatory roles of IL-23/IL-17 axis in the lesions of oral lichen planus |
Q51990326 | Plaque psoriasis vs. atopic dermatitis and lichen planus: a comparison for lesional T-cell subsets, epidermal proliferation and differentiation. |
Q44074112 | Potential pathogenetic role of Th17, Th0, and Th2 cells in erosive and reticular oral lichen planus |
Q50903920 | Reduced immune responses to purified protein derivative and Candida albicans in oral lichen planus. |
Q39912886 | Regulation of CXCL9/10/11 in oral keratinocytes and fibroblasts |
Q38676214 | Role of distinct CD4(+) T helper subset in pathogenesis of oral lichen planus |
Q90064839 | Role of interleukin-4 in pathogenesis of oral lichen planus: A systematic review |
Q36148820 | Salivary Interferon Gamma and Interleukin-4 Levels in Patients Suffering from Oral Lichen Planus. |
Q83835202 | Salivary and serum interleukin-18 in patients with oral lichen planus: a study in an ethnic Chinese population |
Q39625855 | Salivary level of interleukin-8 in oral precancer and oral squamous cell carcinoma |
Q38681872 | Salivary levels of interleukin-8 in oral lichen planus and diabetic patients: A biochemical study. |
Q42149427 | Salivary total antioxidant capacity and lipid peroxidation in patients with erosive oral lichen planus |
Q39178821 | Serum level of Interleukin-8 in subjects with diabetes, diabetes plus oral lichen planus, and oral lichen planus: A biochemical study |
Q35969335 | TGF-beta signal transduction in oro-facial health and non-malignant disease (part I). |
Q35741166 | Th1/Th2 cytokine ratio in tissue transudates from patients with oral lichen planus |
Q84356840 | The possible roles of OPN-regulated CEACAM1 expression in promoting the survival of activated T cells and the apoptosis of oral keratinocytes in oral lichen planus patients |
Q37072701 | The presence of bacteria within tissue provides insights into the pathogenesis of oral lichen planus |
Q26775973 | The wonderous chaperones: A highlight on therapeutics of cancer and potentially malignant disorders |
Q36295299 | Tissue-specific regulation of CXCL9/10/11 chemokines in keratinocytes: Implications for oral inflammatory disease |
Q50993513 | Topical pimecrolimus effect on Fas inducing apoptosis in oral lichen planus: a clinical immunohistochemical study. |
Q54413845 | Tumour necrosis factor-alpha gene polymorphisms and susceptibility to oral lichen planus. |
Q53296760 | [Verrucous squamous cell carcinoma complicating hypertrophic lichen planus. Three case reports and review of the literature]. |
Q36919722 | p38 MAPK signaling in oral-related diseases |
Search more.